# Verve Therapeutics, Inc.

Verve Therapeutics, Inc. is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** Verve Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boston, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001840574

## About

Verve Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001840574, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-27, it reported net income of USD -198,709,000; total assets of USD 647,392,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$198.7M (USD -198,709,000)
- **Total assets:** $647.4M (USD 647,392,000)
- **Cash and equivalents:** $172.6M (USD 172,560,000)
- **Operating cash flow:** -$157.7M (USD -157,692,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$200.1M (USD -200,068,000)
- **Total assets:** $752.7M (USD 752,688,000)
- **Cash and equivalents:** $206.2M (USD 206,180,000)
- **Operating cash flow:** -$149.5M (USD -149,549,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$157.4M (USD -157,387,000)
- **Total assets:** $679.2M (USD 679,223,000)
- **Cash and equivalents:** $115.4M (USD 115,412,000)
- **Operating cash flow:** -$122.3M (USD -122,332,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$120.3M (USD -120,314,000)
- **Total assets:** $384.1M (USD 384,124,000)
- **Cash and equivalents:** $64.3M (USD 64,330,000)
- **Operating cash flow:** -$77.9M (USD -77,880,000)

## Recent SEC filings

- Form 8-K — filed 2025-07-25 — period 2025-07-23 — 8-K
- Form 8-K — filed 2025-07-15 — period 2025-07-14 — 8-K
- Form 8-K — filed 2025-06-17 — period 2025-06-16 — 8-K
- Form 8-K — filed 2025-06-10 — period 2025-06-05 — 8-K
- Form 10-Q — filed 2025-05-14 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-14 — period 2025-05-14 — 8-K
- Form DEF 14A — filed 2025-04-25 — period 2025-06-05 — DEF 14A
- Form 8-K — filed 2025-04-14 — period 2025-04-14 — 8-K
- Form 10-K — filed 2025-02-27 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-02-27 — period 2025-02-27 — 8-K
- Form SC 13G — filed 2024-11-18 — SCHEDULE 13G
- Form 10-Q — filed 2024-11-05 — period 2024-09-30 — 10-Q

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/verve-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology